The commercial relationship with a peptide raw material manufacturer is ultimately governed by contracts — and the terms of those contracts can have significant practical consequences when things go wrong. Understanding the key terms that should be addressed in a manufacturing services agreement (MSA) or supply contract helps buyers protect their interests and establish clear expectations with manufacturers.
Core Contract Elements for Peptide Raw Material Manufacturers
Scope of Services
The contract should precisely define what the manufacturer is engaged to do — including the specific synthesis, purification, analysis, and documentation services to be provided for each order. A clear scope prevents disputes about what was and was not included.
Specifications and Acceptance Criteria
The contract should reference or include the agreed specifications for the peptide raw materials to be supplied. Material that does not meet specification is not acceptable — and the contract should establish this clearly. Reference to the quality agreement (discussed in our separate article) is appropriate for pharmaceutical-grade supplies.
Delivery Terms
- Delivery point: when and where delivery occurs (ex-works at manufacturer’s facility, or delivered to buyer’s facility)
- Risk of loss: when risk transfers from manufacturer to buyer
- Incoterms: international shipments should specify the applicable Incoterms (e.g., DDP — Delivered Duty Paid — or EXW — Ex Works)
- Title transfer: when legal ownership of the material transfers
For cold-chain shipments, clear delivery terms that establish responsibility for temperature excursions in transit are particularly important.
Warranties
Manufacturers should warrant that:
- Peptide raw materials supplied meet the agreed specifications at time of delivery
- Materials are manufactured in accordance with the agreed process (and applicable regulatory standards for GMP materials)
- Materials do not infringe third-party intellectual property
Warranty period — how long after delivery the warranty applies — is a negotiable term. Six to twelve months is typical for research-grade materials; longer may be appropriate for pharmaceutical applications.
Liability Limitations and Indemnification
- Liability cap: most manufacturers limit their total liability to a multiple of the contract value (often 1x to 3x the order value) — excluding losses from personal injury, fraud, or willful misconduct
- Consequential damages: manufacturers typically exclude consequential, indirect, and punitive damages
- Indemnification: each party typically indemnifies the other for losses arising from its own breach, negligence, or intellectual property infringement
For pharmaceutical programs, indemnification for product liability arising from the use of the manufacturer’s material in a drug product is a material negotiation point.
Confidentiality
Even where a separate NDA exists, the manufacturing contract should include confidentiality provisions consistent with the NDA and covering the specific information shared during manufacturing.
Force Majeure
What happens if the manufacturer cannot perform due to circumstances beyond their control (natural disaster, pandemic, regulatory action)? Force majeure provisions should include notification obligations and a resolution process.
Governing Law and Dispute Resolution
Specify which jurisdiction’s law governs the contract and how disputes will be resolved (litigation, arbitration, or mediation). For international relationships with Asian manufacturers, these provisions require careful consideration given differences in legal system and enforcement mechanisms.
Practical Negotiation Points
Right to Audit
Include an explicit right to audit the manufacturer’s facility and quality records with reasonable notice. Some manufacturers include audit rights only in quality agreements; it should be in the commercial contract as well.
Change Management
Require advance notice for any changes to process, materials, equipment, or site. For pharmaceutical programs, this is essential and mirrors the change control provisions in the quality agreement.
Ordering Process and Cancellation
Define the ordering process, confirmation timelines, and cancellation terms — including what fees apply if an order is cancelled after synthesis has commenced.
FAQ
Q: Should we use the manufacturer’s standard terms and conditions or negotiate our own?
Manufacturer standard terms are typically written to protect the manufacturer. For significant or ongoing relationships — particularly pharmaceutical programs — buyers should negotiate bespoke terms or at minimum negotiate key provisions of the manufacturer’s standard terms. For small, one-off research peptide orders, manufacturer standard terms may be acceptable with review.
Q: How do we enforce contract terms with an overseas peptide raw material manufacturer?
International contract enforcement is complex. Practical protections include: specifying a neutral arbitration venue (e.g., ICC arbitration in a neutral location), using escrow arrangements for large payments, and building financial protections (e.g., payment after delivery and acceptance) into the commercial structure.
Conclusion
Clear, comprehensive contract terms with peptide raw material manufacturers establish the commercial and legal framework for a productive relationship and provide recourse when problems arise. Investing in appropriate legal review of manufacturing service agreements — particularly for significant pharmaceutical programs — is a sound risk management measure that protects both the program investment and the intellectual property it represents.
Product Disclaimer & Terms of Use
IMPORTANT NOTICE: FOR RESEARCH USE ONLY (RUO)
This product is intended exclusively for laboratory research and scientific development purposes. It is NOT a drug, food, medical device, cosmetic, or diagnostic product.